Milo Healthcare: Revolutionizing Medical Device Clinical Trials
Medical device clinical trial suites are designed to engage patients and enhance the speed and agility of clinical research. The products are cloud-based solutions built to improve the clinical trial process and are interoperable with existing systems. Discover how Milo Healthcare’s innovative platform transforms traditional clinical data collection through AI-powered voice technology, synthetic arms capabilities, and seamless integration with healthcare workflows. Our solution eliminates paper-based processes while maintaining the highest standards of compliance and data reliability.
Eclevar x RegenLab: Innovation in Clinical Trials
Discover our exclusive interview with Antoine Turzi, CEO of RegenLab, where he shares why leading MedTech companies choose Eclevar for their pivotal clinical trials. In this in-depth conversation, Antoine discusses the challenges of conducting compliant studies, the revolutionary impact of our Milo Healthcare platform with AI and voice technology, and how Eclevar’s expertise in MDR regulation and PMCF requirements delivers reliable results. From diabetic foot ulcer trials to PRP therapies, learn how our partnership approach transforms pilot studies into successful pivotal trials across Europe.
Give your trial the best chance of success
Medtech Clinical trial Site selection using Eclevar is data-first strategy to validate your assumptions and make the right decisions throughout the clinical trial feasibility process—from clinical trial study planning and clinical protocol design to country and site scenario planning and site selection.
Our History & Growth
Eclevar was established in October 2020 to address the evolving landscape of medical device regulation, specifically focusing on CE-Mark approval processes and post-market patient data obligations under the European Union’s MDR 2017/745 regulation. The company delivers comprehensive, interconnected regulatory services while leveraging its established network of Key Opinion Leaders (KOLs) specializing in cardiology, chronic wound care, urology and spine.
Since 2022, Eclevar has achieved substantial growth through strategic international expansion, successfully recruiting senior executives across key markets including the United Kingdom, Germany, and Japan.
MEDICAL DEVICE CRO FROM PREMARKET TO POST MARKET CLINICAL FOLLOW-UP (PMCF)
ECLEVAR MEDTECH is a unique CRO, it brings Competent Authority, notified body, industry and CRO expertise together to overcome your clinical evaluation (CER) , clinical trials and regulatory challenges.
We work according to the following internationals standard
ECLEVAR is proud to be selected as part of the UK government's efforts to become a global leader in innovation and high-growth industries.
ECLEVAR is now eligible for the
French Innovation Tax Credit CII – a key milestone in supporting our R&D efforts.
Latest news
Our latest pictures and video
Balancing Regulatory Requirements, Clinical Evaluation, and Business Risks and Objectives
Competent authorities around the world exchanges information’s about your products risk and efficacy who put your business on stake. ECLEVAR MEDTECH can see your challenges from different angles for better support and understanding. From clinical reports to clinical data collection.
With an international team that encompass: Former Competent Authority/notified body experts, Clinical Evaluation and PMCF experts from the industry, Medical device CRO experts, Key opinions leader for better understanding of your products
Within 3 years, ECLEVAR delivered transformative solutions.
Our partners and medical device associations
